EU strengthens supervision of Huahai pharmaceutical industry

                                                                                    INQUIRY

      The European Medicines Agency said Monday that European authorities are stepping up supervision of the Zhejiang Huahai Pharmaceutical Industry (600521.SS). A possible carcinogen was discovered in the company's Valsartan, an antihypertensive drug.
The European Medical Authority said Monday that European authorities will now monitor the production of other active substances produced by Huahai Pharmaceutical Industry more closely.
European authorities said late last month that they found Huahai Pharmaceuticals did not comply with good production practices and that the company was no longer authorized to produce valsartan at its offshore pharmaceutical plant in China.
In July, Huahai pharmaceutical recalled valsartan in the United States. It was found that one of the impurities in the drug might cause cancer.
Regulators in Europe and North America last month found a second toxin in Valsartan that could cause cancer in humans.


INQUIRY sales@hellerbearings.com
  • Details： EU strengthens supervision of Huahai pharmaceutical industry

  • Like Model No.:

  • We cooperate with UPS,TNT,FEDEX,EMS,DHL,etc.They guarantee to meet your needs in terms of time and money,even if you need your EU strengthens supervision of Huahai pharmaceutical industry bearing tomorrow morning (aka overnight or next day air) on your desk, 2, 3 days or more.Note to international customers, YES, we ship worldwide. INQUIRY -->

    Hot Model No.: